Request Deal Involvement

Eris Lifesciences completed the acquisition of Indian branded formulations business unit of Biocon Biologics for $150m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

J. Sagar Associates

legal advisors

J. Sagar Associates

Khaitan & Co

legal advisors

Khaitan & Co

or

Principals

BIOCON BIOLOGICS (INDIAN BRANDED FORMULATIONS BUSINESS UNIT)

target

BIOCON BIOLOGICS (INDIAN BRANDED FORMULATIONS BUSINESS UNIT)

BIOCON BIOLOGICS LTD

vendor

BIOCON BIOLOGICS LTD

ERIS LIFESCIENCES

bidder

ERIS LIFESCIENCES

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Eris Lifesciences completed the acquisition of Indian branded formulations business unit of Biocon Biologics for $150m.